Olympus Medical Systems
- Company typePublic
- Founded1919
- HeadquartersCenter Valley, United States
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
Olympus Medical Systems firmographics
Firmographics- Name
- Olympus Medical Systems
- Legal name
- Olympus Corporation of the Americas
- Website
- https://medical.olympusamerica.com
- Company type
- Public
- Founded year
- 1919
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Ownership category
- akta.pro rank
Olympus Medical Systems industry classification
Industry- Product category
- Medical Endoscopy Systems
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation) (HLAHADAB)
- akta.pro secondary industry
- Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools) (HLAHADAN)
Keywords
Where Olympus Medical Systems is headquartered
LocationHeadquarters
- HQ city
- Center Valley
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
Olympus Medical Systems business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure
Revenue model
- Capital Equipment Sales: Olympus generates revenue from sale of capital medical equipment including endoscopy systems, surgical imaging platforms, ultrasound processors, and reusable surgical devices to hospitals and healthcare systems.
- Single-Use Medical Devices: Recurring revenue from single-use devices including bronchoscopes, rhinolaryngoscopes, biopsy needles, surgical sealers, and accessories used in procedures.
- Service and Repair: Olympus provides service and repair capabilities through MyOlympus Service portal, service agreements, and certified pre-owned equipment programs.
- Financing and Leasing Programs: Olympus offers leasing and financing programs for healthcare facilities to acquire capital equipment, providing flexible payment options.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Multi-year contract | Capital equipment pricing varies by system configuration and volume |
Go-to-market motion3 records
Distribution channels7 records
Marketing channels7 records
Olympus Medical Systems product offering
Product offeringCore offering
Olympus Medical Systems develops, manufactures, and distributes endoscopy systems, surgical imaging platforms, and minimally invasive therapeutic devices for the early detection, diagnosis, and treatment of gastrointestinal, urological, respiratory, and surgical conditions in healthcare facilities. Its portfolio spans capital equipment, single-use devices, and AI-enabled software platforms serving hospitals, ambulatory surgical centers, and federal healthcare facilities.
Product overview
Olympus Medical Systems offers a comprehensive portfolio of medical devices and platforms for endoscopy-enabled care across gastroenterology, urology, respiratory/pulmonology, and surgical specialties. The portfolio includes core endoscopy systems (EVIS X1), surgical imaging platforms (VISERA ELITE III developed with Sony), ultrasound systems (Aplio i800 EUS via Canon partnership, EU-ME3), AI-enabled detection solutions (OLYSENSE platform with CADDIE), single-use scopes (H-SteriScope bronchoscopes, E-SteriScope rhinolaryngoscopes), surgical energy devices (POWERSEAL, Thunderbeat), advanced visualization scopes (ENDOEYE 3D, ENDOCUFF VISION), tissue management tools (DIEGO ELITE, Celeris), ERCP devices (TJF-Q190V duodenoscope, VisiGlide, CleverCut3V), and workflow management platforms (Knowledge Exchange System, EBUS Solution, Systems Integration). The company also distributes third-party products (GORE VIABIL stents) and is expanding through acquisitions (BioProtect Balloon Spacer) and partnerships (EndoRobotics robotics).
Differentiator
Problem solved
Functional benefit
Brands
- EVIS X1: Advanced endoscopy system featuring Extended Depth of Field (EDOF) technology for precise observation through continuous broad focus and seamless magnification.
- VISERA ELITE III
- POWERSEAL
- H-SteriScope
- OLYSENSE
- ENDOEYE FLEX 3D
- Thunderbeat
- Spiration Valve System
- SecureFlex FNB
- E-SteriScope
- Olympus Innovation Ventures (OIV)
Products and services
- EVIS X1 Endoscopy System
- VISERA ELITE III Surgical Imaging Platform
- OLYSENSE Platform
- Aplio i800 EUS Ultrasound System
- EU-ME3 Ultrasound Processor
- H-SteriScope Single-Use Bronchoscopes
- E-SteriScope Single-Use Rhinolaryngoscope
- Thunderbeat Tissue Management
- POWERSEAL Sealer/Divider
- ENDOEYE FLEX 3D
- DIEGO ELITE Multidebrider
- Celeris Single-Use Microdebrider
- TJF-Q190V Duodenoscope
- SecureFlex FNB Needle
- CleverCut3V Sphincterotomes
- VisiGlide Guidewires
- HD Flexible Cystoscope
- Plasma-OvalButton
- Olympus EBUS Solution
- Olympus Knowledge Exchange System
- Olympus Systems Integration
- BioProtect Balloon Spacer
- EndoRobotics Robot-Assisted Technologies
Quantifiable outcome
- 7.3% absolute increase in adenoma detection rate (ADR) with CADDIE AI-assisted colonoscopy vs standard colonoscopy
- +5 more outcomes
Companies that use Olympus Medical Systems
Customer profileNamed customers8 records
Segments7 records
Ideal customer profiles3 records
Olympus Medical Systems technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
AI capability5 records
Feature12 records
Olympus Medical Systems partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core and minor.
- BioProtect Ltd.coreOlympus announced definitive agreement to acquire BioProtect Ltd. for $270 million to expand portfolio of urological technologies and address prostate cancer. BioProtect develops the Balloon Spacer system for rectal spacing during prostate cancer radiation therapy, which has been used in 11,000+ procedures worldwide. Acquisition aligns with Olympus' strategic pillar of Innovation-driven Growth.
- Hunan Vathin Medical Instrument Co., Ltd.coreVathin E-SteriScope single-use rhinolaryngoscopes and H-SteriScope single-use bronchoscopes manufactured by Vathin Medical are distributed exclusively by Olympus. The products complement Olympus' reusable scope portfolio with single-use options for enhanced patient safety and procedural flexibility.
- EndoRobotics Co., Ltd.coreExclusive global distribution agreement for robot-assisted technologies manufactured by EndoRobotics as part of Olympus' EndoTherapy portfolio. Partnership aims to drive broader adoption of advanced endoscopic procedures such as endoscopic submucosal dissection (ESD) and help clinicians deliver organ-sparing, minimally invasive care with precision and confidence.
- Canon Inc./Canon Medical Systems USAcoreStrategic partnership for exclusive distribution of Canon-manufactured Aplio i800 EUS premium ultrasound system in the U.S., its territories, Puerto Rico, and Bermuda. The system offers advanced EUS imaging with Shear Wave Elastography, Attenuation Imaging, Superb Micro-vascular Imaging, and Smart 3D capabilities for GI and pulmonary applications.
- First Nation GroupcoreAuthorized SDVOSB reseller agreement for federal healthcare facilities. First Nation Group, a Service-Disabled Veteran-Owned Small Business, provides federal customers including VA, DoD, IHS, and NIH with access to Olympus capital equipment and single-use devices. The 3-year agreement supports government agencies in achieving SDVOSB procurement objectives.
- DSS Imagetech / MBF BioscienceminorExpert-led webinar series celebrating 'Microscopy Month' and World Microscopy Day featuring sessions on advanced imaging technologies including SLICE light sheet imaging, Abberior Super Resolution Nanoscopy, and Evident Microscopy solutions. Olympus Medical Systems India participates as expert panel member.
- Campanha Marco Azul (SOBED, SBCP, FBG)minorOlympus Grants Committee approved short-term product loan supporting Brazil's Campanha Marco Azul colorectal cancer awareness initiative. Loan enabled 624 no-cost colonoscopies, removal of 300+ polyps, and diagnosis of 8 advanced cancers in underserved population.
- American Society of Gastrointestinal Endoscopy (ASGE)coreASGE, a nonprofit medical society with more than 17,000 members worldwide, received a $1 million+ permanent product award from Olympus including six EVIS X1 endoscopy systems. Equipment supports hands-on training at ASGE's Institute of Training and Technology serving approximately 1,200 learners annually including nearly 500 first-year fellows.
- W. L. Gore & AssociatescoreExclusive global distribution rights for GORE VIABIL Biliary Endoprosthesis transferred from Gore to Olympus. The fully covered self-expanding metal stent provides differentiated alternative for palliation of malignant biliary strictures. Commercial support transitioned to Olympus January 1, 2026.
- ConMed CorporationminorConMed previously supported GORE VIABIL Biliary Endoprosthesis distribution in the U.S. until December 31, 2025. The transition ensures continuity of service and access for healthcare providers and patients during the commercial change to Olympus distribution.
- Swan EndoSurgicalminorSwan EndoSurgical is an emerging leader in flexible endoluminal surgical robotics, co-founded by Revival Healthcare Capital and Olympus. Company is focused on delivering a fully integrated flexible endoluminal robotic platform for complex gastrointestinal interventions.
Scale indicators8 records
Recent moves8 records
Expansion highlights7 records
Olympus Medical Systems competitors and assessment
Company assessmentBroad incumbents
- Stryker: Diversified MedTech incumbent with a large surgical and endoscopy portfolio (1588/1688 AIM camera platforms, surgical visualization, PowerSeal-style energy devices) and a Robotics & Enabling Technologies division. Overlaps with Olympus in surgical imaging, energy, and increasingly single-use scopes.
- Medtronic: Broad incumbent in GI (GI Genius AI polyp detection), surgical stapling, energy, and advanced ablation. Specifically competes with Olympus in GI AI detection, colorectal surgery, and ENT/pulmonary platforms; named alongside Olympus as a key player in the lung cancer surgery market.
- Ethicon (Johnson & Johnson MedTech): Broad incumbent in advanced and laparoscopic surgical energy (ENSEAL, HARMONIC), stapling, and biosurgery. Competes directly with Olympus POWERSEAL and THUNDERBEAT in the same multi-specialty minimally invasive surgery capital sales cycles.
Emerging players
- Intuitive Surgical: Adjacent competitor in minimally invasive surgery via the da Vinci robotic platform and emerging Ion robotic bronchoscopy for lung biopsy. Represents the primary long-term competitive risk to Olympus' surgical imaging and lung cancer franchises as robotic surgery expands.
- Teleflex: Emerging competitor in interventional pulmonology and urology with single-use bronchoscopes (Muffin, TotalDrive) and urological devices. Listed alongside Olympus as a key player in the lung cancer surgery market with a meaningful but more focused portfolio overlap.
Direct peers
- Boston Scientific: Direct peer in GI endoscopy (SpyGlass DS cholangioscopy, hemostasis clips, resection devices), urology (LithoVue ureteroscopy, Rezum BPH), and pulmonary (single-use bronchoscopy via the acquisition of Apollo Endosurgery and other assets). Heavily overlaps Olympus' therapeutic endotherapy and single-use franchises.
- Pentax Medical (HOYA): Direct peer in flexible endoscopy systems (i20, OPTIVISTA) with strong i-scan imaging and growing single-use bronchoscope offerings. Competes against EVIS X1 in GI and increasingly in therapeutic pulmonology and ENT.
- Karl Storz: German privately-held endoscopy systems and instruments manufacturer that competes head-to-head with Olympus across rigid and flexible endoscopy, laparoscopy, and urology visualization. Most direct peer in core endoscopy towers (rigid/flexible scopes, cameras, light sources) and a frequent co-bidder in hospital capital tenders.
- Fujifilm Healthcare: Direct peer in endoscopy towers (ELUXEO, BL-7000 series), EUS, and AI-assisted colonoscopy via its REiLI platform. Third-party AI vendors (L Pixel) explicitly build compatibility for both Olympus and Fujifilm systems, underscoring their head-to-head positioning.
Regional players
- ConMed: Surgical and gastrointestinal competitor in insufflation, electrosurgery, and endomechanical devices. Previously distributed GORE VIABIL biliary stents in the U.S. through end of 2025, then transitioned commercial support to Olympus—illustrating direct overlap in the Olympus EndoTherapy customer base.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
Olympus Medical Systems social profiles
Digital presenceOlympus Medical Systems compliance and trust
Trust signalCompliance7 records
Olympus Medical Systems financial estimates
Financial estimateRevenue estimate
Valuation estimate
Olympus Medical Systems leadership team
Management profileNumber of profiles
Olympus Medical Systems subsidiaries and ownership
Company hierarchySubsidiaries5 records
Olympus Medical Systems funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Olympus Medical Systems M&A and investment
M&A and investmentM&A
Investments3 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Olympus Medical Systems
What does Olympus Medical Systems do?
Olympus Medical Systems develops, manufactures, and distributes endoscopy systems, surgical imaging platforms, and minimally invasive therapeutic devices for the early detection, diagnosis, and treatment of gastrointestinal, urological, respiratory, and surgical conditions in healthcare facilities. Its portfolio spans capital equipment, single-use devices, and AI-enabled software platforms serving hospitals, ambulatory surgical centers, and federal healthcare facilities.
Is Olympus Medical Systems a public or private company?
Olympus Medical Systems is a public company. It is classified as corporate owned and is currently operating.
When was Olympus Medical Systems founded?
Olympus Medical Systems was founded in 1919. It employs 1,001 to 5,000 people.
Where is Olympus Medical Systems based?
Olympus Medical Systems is headquartered in Center Valley, United States, in the North America region.
How does Olympus Medical Systems make money?
Four revenue lines are on record. Capital Equipment Sales are the primary driver. The others are single-Use Medical Devices, service and Repair and financing and Leasing Programs.
Who are Olympus Medical Systems's main competitors?
Broad incumbents on record are Stryker, Medtronic and Ethicon (Johnson & Johnson MedTech). Emerging players are Intuitive Surgical and Teleflex. Direct peers are Boston Scientific, Pentax Medical (HOYA), Karl Storz and Fujifilm Healthcare. ConMed is listed as a regional player.
Does Olympus Medical Systems have an API?
No public API is recorded for Olympus Medical Systems.
What industry is Olympus Medical Systems in?
Olympus Medical Systems's product category is Medical Endoscopy Systems. Its primary akta.pro industry code is HLAHADAB, Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation), with a secondary code of HLAHADAN, Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools). Its NAICS code is 339112 and its SIC code is 3841.